The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy
Open accessAbstract
Objective Elevated inflammatory cytokine levels have been implicated in the pathogenesis of non-healing chronic venous insufficiency (CVI) ulcers. The goal of this study was to determine the protein levels of a wide range of inflammatory cytokines in untreated CVI ulcer tissue before and after 4 weeks of high-strength compression therapy. These levels were compared to cytokines present in healthy tissue.Methods Thirty limbs with untreated CVI and leg ulceration received therapy for 4 weeks with sustained high-compression bandaging at an ambulatory wound center. Biopsies were obtained from healthy and ulcerated tissue before and after therapy. A multiplexed protein assay was used to measure multiple cytokines in a single sample. Patients were designated as rapid or delayed healers based on ulcer surface area change.Results The majority of pro-inflammatory cytokine protein levels were elevated in ulcer tissue compared to healthy tissue, and compression therapy significantly reduced these cytokines. TGF-beta1 was upregulated in ulcer tissue following compression therapy. Rapid healing ulcers had significantly higher levels of IL-1alpha, IL-1beta, IFN-gamma, IL-12p40, and granulocyte macrophage colony stimulating factor (GM-CSF) before compression therapy, and IL-1 Ra after therapy. IFN-gamma levels significantly decreased following therapy in the rapidly healing patients.Conclusion CVI ulcer healing is associated with a pro-inflammatory environment prior to treatment that reflects metabolically active peri-wound tissue that has the potential to heal. Treatment with compression therapy results in healing that is coupled with reduced pro-inflammatory cytokine levels and higher levels of the anti-inflammatory cytokine IL-1 Ra.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, recent investigations of chronic wound tissue and fluid indicate a continual competition between inflammatory and anti-inflammatory signals leading to a misbalanced environment for proper wound healing to occur (25, 26).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [26]
In the citing paper
“As a result, deregulation of several key proinflammatory cytokines, such as IL-1β and tumor necrosis factor–α (TNFα), prolong the inflammatory phase and delay healing (26, 29).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.
(1975) · PubMed Central · Cited by 1,437
Compression for venous leg ulcers
O’Meara, S., Cullum, N. A., Nelson, E. A., & Dumville, J. C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000265.pub3 · Cited by 936
PDGF and FGF stimulate wound healing in the genetically diabetic mouse.
Greenhalgh, D. G., Sprugel, K. H., Murray, M. J., & Ross, R. (1990) · Europe PMC (PubMed Central) · Cited by 681
Hübner, G., Brauchle, M. A., Smola, H., Madlener, M., Fässler, R., & Werner, S. (1996) · Cytokine · doi:10.1006/cyto.1996.0074 · Cited by 499
Definition of venous reflux in lower-extremity veins
Labropoulos, N., Tiongson, J. E., Pryor, L., Tassiopoulos, A. K., Kang, S. S., Mansour, M., & Baker, W. H. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00424-5 · Cited by 469
Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers
Trengove, N. J., Bielefeldt‐Ohmann, H., & Stacey, M. C. (2000) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2000.00013.x · Cited by 432
Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay
Carson, R. T., & Vignali, D. A. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00069-1 · Cited by 404
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Leibovich, 1975, The role of the macrophage in wound repair, Am J Pathol, 78, 71
Cited by
Sorted by citations
Wound repair and regeneration: Mechanisms, signaling, and translation
Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562
“Specifically, recent investigations of chronic wound tissue and fluid indicate a continual competition between inflammatory and anti-inflammatory signals leading to a misbalanced environment for proper wound healing to occur (25, 26).”
Diabetic Wound-Healing Science
Burgess, J. L., Wyant, W. A., Abujamra, B. A., Kirsner, R. S., & Jozic, I. (2021) · Medicina · doi:10.3390/medicina57101072 · Cited by 1,024
“tumor necrosis factor (TNF)-α, and plasma C reactive protein [85,88,90,91], and bacterial proliferation [88,92] being the most explored factors that contribute to the impaired healing process.”
BackgroundO’Donnell, T. F., Passman, M. A., Marston, W. A., Ennis, W. J., Dalsing, M. C., Kistner, R. L., Lurie, F., Henke, P. K., Gloviczki, M. L., Eklöf, B., et al. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.049 · Cited by 729
Self-citationLiu, W., Yu, M., Xie, D., Wang, L., Cheng, Y., Zhu, Q., Liu, F., & Yang, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01756-x · Cited by 519
Pranantyo, D., Yeo, C. K., Wu, Y., Fan, C., Xu, X., Yip, Y. S., Vos, M. I. G., Mahadevegowda, S. H., Lim, P. L. K., Yang, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44968-y · Cited by 408
“leads to a redox imbalance and prevention of the proper wound healing occurrence 10,11 .”
Lohmann, N., Schirmer, L., Atallah, P., Wandel, E., Ferrer, R. A., Werner, C., Simon, J. C., Franz, S., & Freudenberg, U. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai9044 · Cited by 360
“Consistent with other studies (7, 48), high concentrations of proinflammatory chemokines and cytokines including MCP-1, IL-8, MIP-1a, MIP-1b, TNF, and IL-1b (table S1) were quantified in these exudates with peak concentrations of IL-8 ranging from 251 to 1231 ng/ml and ofMCP-1 from 173 to 2839 pg/ml (table S2).”
ResultRaffetto, J. D., Ligi, D., Maniscalco, R., Khalil, R. A., & Mannello, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010029 · Cited by 356
“↑ TGF-β1 and IL-1ra, and ↓IFN-γ in healing ↑ IL-1α, IL-1β, IFN-β, IL-12p40, and GM-CSF in non-healing Ulcer tissue [87]”
BackgroundManagement of Patients With Venous Leg Ulcers: Challenges and Current Best Practice
Franks, P. J., Barker, J., Collier, M. A., Gethin, G., Haesler, E., Jawień, A., Laeuchli, S., Mosti, G. B., Probst, S., & Weller, C. D. (2016) · Journal of Wound Care · doi:10.12968/jowc.2016.25.sup6.s1 · Cited by 313
Zhu, S., Zhao, B., Li, M., Wang, H., Zhu, J., Li, Q., Gao, H., Feng, Q., & Cao, X. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.03.005 · Cited by 254
“In general, the healing process of diabetic wounds usually stagnates in inflammation phase, which is mainly regulated by macrophages [29].”
BackgroundOral wound healing models and emerging regenerative therapies
Toma, A. I., Fuller, J. M., Willett, N. J., & Goudy, S. L. (2021) · Translational research · doi:10.1016/j.trsl.2021.06.003 · Cited by 263
Brown, M. S., Ashley, B. K., & Koh, A. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00047 · Cited by 233
“7 pg/μg which serve as indicators of inflammation and elevated metalloproteinases (Bastard et al., 2000; Beidler et al., 2009; Huang et al., 2013).”
BackgroundCellular events and biomarkers of wound healing
Yussof, S. J. M., Omar, E., Pai, D. R., & Sood, S. (2012) · Indian Journal of Plastic Surgery · doi:10.4103/0970-0358.101282 · Cited by 218
Bacterial Biofilm in Chronic Wounds and Possible Therapeutic Approaches
Cavallo, I., Sivori, F., Mastrofrancesco, A., Abril, E., Pontone, M., Domenico, E. G. D., & Pimpinelli, F. (2024) · Biology · doi:10.3390/biology13020109 · Cited by 234
“The deregulation of several key proinflammatory cytokines, such as IL-1 β and TNF-α , maintains an inflammatory phase, which causes a delay in healing [47].”
BackgroundCompression therapy in mixed ulcers increases venous output and arterial perfusion
Mosti, G. B., Iabichella, M. L., & Partsch, H. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.07.071 · Cited by 191
The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease
Castro‐Ferreira, R., Cardoso, R., Leite-Moreira, A. F., & Mansilha, A. (2017) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2017.06.131 · Cited by 193
Biomarkers for wound healing and their evaluation
Patel, S. B., Maheshwari, A., & Chandra, A. (2016) · Journal of Wound Care · doi:10.12968/jowc.2016.25.1.46 · Cited by 185
Admin, A., Theocharidis, G., Baltzis, D., Roustit, M., Tellechea, A., Dangwal, S., Khetani, R. S., Shu, B., Zhao, W., Fu, J., et al. (2020) · Diabetes · doi:10.2337/db20-0188 · Cited by 188
Pathophysiology of Chronic Venous Disease and Venous Ulcers
Raffetto, J. D. (2018) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.11.002 · Cited by 175
The role of TGFβ in wound healing pathologies
Kiritsi, D., & Nyström, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.11.004 · Cited by 173
New diagnostic modalities in the evaluation of lymphedema
O’Donnell, T. F., Rasmussen, J. C., & Sevick-Muraca, E. M. (2017) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2016.10.083 · Cited by 168
Xu, Q., Guo, L., Sigen, A., Gao, Y., Zhou, D., Greiser, U., Creagh-Flynn, J., Zhang, H., Dong, Y., Cutlar, L., et al. (2018) · Chemical Science · doi:10.1039/c7sc03913a · Cited by 170
Graduated compression stockings
Lim, C. S., & Davies, A. H. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.131281 · Cited by 163
“It also initiates complex physiologic and biochemical effects involving the venous, arterial and lymphatic systems, although the exact mechanisms remain unclear.(2,4,5) One study that used near-infrared spectroscopy to monitor changes in tissue oxy hemo globin and deoxyhemoglobin re ported that limb oxygenation increa…”
BackgroundTherapeutic role of growth factors in treating diabetic wound
Zheng, S.-Y., Wan, X.-X., Kambey, P. A., Luo, Y., Hu, X., Liu, Y., Shan, J.-Q., Chen, Y., & Xiong, K. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i4.364 · Cited by 147
Pathophysiology of chronic venous disease
Raffetto, J. D., & Khalil, R. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90610-4.00021-5 · Cited by 124
Milić, D. J., Zivic, S. S., Bogdanović, D. C., Jovanović, M. M., Jankovic, R. J., Milosevic, Z. D., Stamenkovic, D. M., & Trenkić-Božinović, M. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.10.042 · Cited by 121
Zhu, S., Dai, Q., Yao, L., Wang, Z., He, Z., Li, M., Wang, H., Li, Q., Gao, H., & Cao, X. (2021) · Composites Part B Engineering · doi:10.1016/j.compositesb.2021.109569 · Cited by 119
Partsch, H., & Mortimer, P. S. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13851 · Cited by 110
Lipoedema: a paradigm shift and consensus
Bertsch, T., Erbacher, G., Elwell, R., & Partsch, H. (2020) · Journal of Wound Care · doi:10.12968/jowc.2020.29.sup11b.1 · Cited by 111
Pyoderma Gangrenosum: Treatment Options
Dissemond, J., Marzano, A. V., Hampton, P. J., & Ortega‐Loayza, A. G. (2023) · Drugs · doi:10.1007/s40265-023-01931-3 · Cited by 97
“When PG occurs on the lower legs, compression bandages should be applied to support anti-inflammatory activity by reducing oedema [95].”
BackgroundCapó, X., Monserrat-Mesquida, M., Quetglas‐Llabrés, M. M., Batle, J. M., Tur, J. A., Pons, A., Sureda, A., & Tejada, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087040 · Cited by 91
“Growth factors are bioactive peptides that act in coordination with cytokines, MMPs, inflammatory cells or other cell types, such as keratinocytes or fibroblasts, to affect wound healing [52].”
BackgroundLurie, F., Lal, B. K., Antignani, P. L., Blebea, J., Bush, R. L., Caprini, J. A., Davies, A. H., Forrestal, M. D., Jacobowitz, G. R., Kalodiki, E., et al. (2018) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2018.10.002 · Cited by 86
Reactive oxygen species and bacterial biofilms in diabetic wound healing
Nouvong, A., Ambrus, A., Zhang, E. R., Hultman, L., & Coller, H. A. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00066.2016 · Cited by 83
“The reason for the increased infiltration of immune cells into chronic wounds is not clear, but chronic wounds have also been found to have higher levels of proinflammatory growth factors and cytokines (3, 24, 27, 82, 89) that may recruit these inflammatory cells.”
BackgroundResveratrol-Induced Signal Transduction in Wound Healing
Pignet, A.-L., Schellnegger, M., Hecker, A., Kohlhauser, M., Kotzbeck, P., & Kamolz, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312614 · Cited by 86
“Resveratrol has the potential to improve wound healing due to its anti-inflammatory, pro-angiogenic and anti-oxidative properties [24,36,47,132].”
BackgroundPathophysiology of venous ulceration
Crawford, J. M., Lal, B. K., Durán, W. N., & Pappas, P. J. (2017) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2017.03.015 · Cited by 82
Role of Endothelial Progenitor Cells and Inflammatory Cytokines in Healing of Diabetic Foot Ulcers
Tecilazich, F., Dinh, T., Pradhan‐Nabzdyk, L., Leal, E. C., Tellechea, A., Kafanas, A., Gnardellis, C., Magargee, M. L., Dejam, A., Toxavidis, V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083314 · Cited by 82
“Our results are compatible with changes that were observed in inflammatory cytokines in biopsies of chronic venous ulcers that were collected before and after four weeks of compression therapy [33].”
ResultVenous leg ulceration pathophysiology and evidence based treatment
Chi, Y., & Raffetto, J. D. (2015) · Vascular Medicine · doi:10.1177/1358863x14568677 · Cited by 77
O’Donnell, T. F., & Passman, M. A. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.058 · Cited by 75
Mota, F. A. R., Passos, M. L. C., Santos, J. L. M., & Saraiva, M. L. M. F. S. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116095 · Cited by 76
Rodrigues, H. G., Vinolo, M. A. R., Sato, F. T., Magdalon, J., Kühl, C. M. C., Yamagata, A. S., Pessoa, A. F. M., Malheiros, G., dos Santos, M. F., Lima, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165115 · Cited by 74
Polylysine for skin regeneration: A review of recent advances and future perspectives
Zarrintaj, P., Ghorbani, S., Barani, M., Chauhan, N. P. S., Yazdi, M. K., Saeb, M. R., Ramsey, J. D., Hamblin, M. R., Mozafari, M., & Mostafavi, E. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10261 · Cited by 65
“An endocytosis inhibitor brefeldin reduced DNA delivery mediated by many cargo-vehicles, such as, PEI, adenovirus, and Lipofectamine-2000.(92) All the non-viral carriers are designed to package exogenous DNA (EDNA) or nucleic acids into a biocompatible complex which can easily be transported and adsorbed into the cell…”
BackgroundInfluentialTisato, V., Zauli, G., Voltan, R., Gianesini, S., di Iasio, M. G., Volpi, I., Fiorentini, G., Zamboni, P., & Secchiero, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039543 · Cited by 67
“Our current findings are in line with previous studies indicating that specific inflammatory mediators are associated with time- and patterndependent healing progression in CVD [29].”
ResultLantis, J. C., Marston, W. A., Farber, A. M., Kirsner, R. S., Zhang, Y., Lee, T. D., Cargill, D. I., & Slade, H. B. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.12.055 · Cited by 67
“0) [6-104] Weight, kg 100 (103 6 34) 102 (108 6 39) 93 (96 6 26) 100 (102 6 34) 95 (101 6 29) 104 (107 6 38) Ankle 103 (45.”
Self-citationComerota, A. J., & Lurie, F. (2015) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2015.07.003 · Cited by 64
“[63] Beidler SK, Douillet CD, Berndt DF, et al.”
BackgroundGualdi, G., Costantini, E., Reale, M., & Amerio, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095037 · Cited by 62
“As a result, deregulation of several key pro-inflammatory cytokines, such as interleukin (IL)-1β and tumor necrosis factor-α (TNF-α), prolong the inflammatory phase and delay healing [44,47].”
BackgroundInflammation in chronic venous ulcers
Raffetto, J. D. (2013) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355513476844 · Cited by 60
Pathophysiology of wound healing and alterations in venous leg ulcers-review
Raffetto, J. D. (2016) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355516632998 · Cited by 62
“Treatment with compression therapy resulted in healing that was coupled with reduced pro-inflammatory cytokine levels and higher levels of the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1 Ra).(13) The role of TGF-b1 in VLU healing was investigated in a study of 80 patients treated with multilayer…”
BackgroundExtracellular matrix-inspired biomaterials for wound healing
Hosty, L., Heatherington, T., Quondamatteo, F., & Browne, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09750-9 · Cited by 63
Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing
Roan, J., Cheng, H.-N., Young, C.-C., Lee, C.-J., Yeh, M., Luo, C.-Y., Tsai, Y.-S., & Lam, C.-F. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.09.024 · Cited by 60
Chronic venous disease – Part I: Inflammatory biomarkers in wound healing
Ligi, D., Mosti, G. B., Croce, L., Raffetto, J. D., & Mannello, F. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.018 · Cited by 60
Involvement of Inflammation and Its Resolution in Disease and Therapeutics
Alfaro, S., Acuña, V., Ceriani, R., Cavieres, M. F., Oppenheimer, C. W., & Campos‐Estrada, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810719 · Cited by 68
“Several causes, such as infection, hypoxia, necrosis, or exudate and pro-inflammatory cytokines, can prolong the phases of wound healing [79,80].”
BackgroundZuliani, T., Saïagh, S., Knol, A., Esbelin, J., & Dréno, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070408 · Cited by 59
“Nonetheless, the upregulated expression of both MHC class I and II observed upon IFN-c stimulation, suggests that alloreactivity of fetal fibroblasts and keratinocytes could be enhanced in chronic cutaneous ulcer and burn wounds, where IFN-c contributes to the local inflammation [25,26].”
BackgroundStout, N., Partsch, H., Szolnoky, G., Forner‐Cordero, I., Mosti, G. B., Mortimer, P. S., Flour, M., Damstra, R. J., Piller, N., Geyer, M. J., et al. (2012) · PubMed · Cited by 59
Lipoedema – myths and facts, Part 5
Bertsch, T., Erbacher, G., Corda, D., Damstra, R. J., van Duinen, K., Elwell, R., Smeenge, J., Faerber, G., Fetzer, S., Fink, J. M., et al. (2020) · Phlebologie · doi:10.1055/a-1012-7670 · Cited by 57
“Beidler et al. likewise demonstrated a decrease in proinflammatory cytokines and macrophages after four weeks ’ compression therapy in patients with chronic venous insufficiency [55].”
BackgroundMosti, G. B., Mancini, S., Bruni, S., Serantoni, S., Gazzabin, L., Bucalossi, M., Polignano, R., Mariani, F., Bastiani, L., Partsch, H., et al. (2019) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355519858439 · Cited by 56
Mannello, F., Ligi, D., Canale, M., & Raffetto, J. D. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.927312 · Cited by 52
“CXC-9 [79] Eotaxin-2 [79] GROa [184] IFN-g [79,185] IL-1a [6,79,128,181,184,185] IL-1b [79,128,181,184,185]”
BackgroundMethodInfluentialLiu, Y. C., Margolis, D. J., & Isseroff, R. R. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.428 · Cited by 52
“Of the 20 studies involving wound fluid or ulcer biopsies, 17 did not exclude patients with diabetes (Harris et al., 1995; Higley et al., 1995; Hasan et al., 1997; Li et al., 1998; Mendez et al., 1999; Trengove et al., 2000; Kim et al., 2003; Lal et al., 2003; Tian and Stacey, 2003; Beidler et al., 2009; Charles et al…”
BackgroundMethodInfluentialVersatile Hyperbranched Poly(β-hydrazide ester) Macromers as Injectable Antioxidative Hydrogels
Xu, Q., Venet, M., Wang, W., Creagh-Flynn, J., Wang, X., Li, X., Gao, Y., Zhou, D., Zeng, M., Lara‐Sáez, I., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b15006 · Cited by 50
Cytokines and Venous Leg Ulcer Healing—A Systematic Review
Burian, E. A., Sabah, L., Karlsmark, T., Kirketerp‐Møller, K., Moffatt, C. J., Thyssen, J. P., & Ågren, M. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126526 · Cited by 50
“Beidler 2009 [36] 29 Cohort 4 weeks Biopsy Luminex, ELISA G-CSF, GM-CSF, IFN-γ, IL-1α, IL-1β, IL-1Ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL12p40, IL-12p70, IL-13, IL-15, IL-17, TGF-β1, TNF-α”
BackgroundInfluentialTrøstrup, H., Lundquist, R., Christensen, L. H., Jørgensen, L. N., Karlsmark, T., Haab, B. B., & Ågren, M. S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10384.x · Cited by 49
Snyder, R., Driver, V. R., Fife, C. E., Lantis, J. C., Peirce, B., Serena, T. E., & Weir, D. (2011) · PubMed · Cited by 45
Schepler, H., Neufurth, M., Wang, S., She, Z., Schröder, H. C., Wang, X., & Müller, W. E. G. (2021) · Theranostics · doi:10.7150/thno.67148 · Cited by 44
“impaired inflammatory cytokine levels, vessel insufficiencies (venous or arterial insufficiencies) are involved in the pathogenesis of non-healing chronic wounds [46].”
BackgroundProteomics in chronic wound research: Potentials in healing and health
Broadbent, J. A., Walsh, T., & Upton, Z. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900152 · Cited by 44
“Dysregulation in the presentation of vascular endothelial growth factor [57, 65, 97], epithelial growth factor [98], hepatocyte growth factor [99], platelet-derived growth factor [82], transforming growth factor-b1 [65, 81, 87, 93, 98, 100, 101], transforming growth factor-b2 [100, 102] and insulin-like growth factor-…”
BackgroundMedical management of venous ulcers
Pascarella, L. E., & Shortell, C. K. (2015) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2015.06.001 · Cited by 41
“In the same study, the concentration of interleukin 1Ra, an inhibitor of the proinflammatory effect of interleukin 1β, was increased after 4 weeks of compression therapy [14].”
BackgroundInfluentialTissue Bioanalysis of Biotherapeutics And Drug Targets to Support Pk/Pd
Neubert, H., Fountain, S. T., King, L., Clark, T. H., Weng, Y., O’Hara, D. M., Li, W., Leung, S. S., RAY, C. A., Palandra, J., et al. (2012) · Bioanalysis · doi:10.4155/bio.12.234 · Cited by 40
Chemokine‐Capturing Wound Contact Layer Rescues Dermal Healing
Schirmer, L., Atallah, P., Freudenberg, U., & Werner, C. (2021) · Advanced Science · doi:10.1002/advs.202100293 · Cited by 42
Fibroblast-like cells Promote Wound Healing via PD-L1-mediated Inflammation Resolution
Wang, X., Guo, W., Qiu, W., Ao, L., Yao, M., Xing, W., Yu, Y., Chen, Q., Wu, X., Li, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69890 · Cited by 35
“It has reported that chronic wound tissue and fluid indicate a continual competition between inflammatory and anti-inflammatory signals leading to a misbalanced environment for proper wound healing to occur, which delays the wound healing [10, 11].”
BackgroundRaffetto, J. D., & Marston, W. A. (2011) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181fcaff2 · Cited by 35
Self-citationCompression therapy in leg ulcers
Partsch, H. (2013) · Reviews in vascular medicine · doi:10.1016/j.rvm.2013.02.001 · Cited by 34
Global Perspective on Diabetic Foot Ulcerations
Dinh, T. (2011) · InTech eBooks · doi:10.5772/1173 · Cited by 34
Epidemiology and aetiology of C4–6 disease
Bradbury, A. W. (2010) · Phlebology The Journal of Venous Disease · doi:10.1258/phleb.2010.010s01 · Cited by 33
Jiang, X., Yao, Z., Wang, K., Lou, L., Xue, K., Chen, J., Zhang, G., Zhang, Y. L., Du, J., Lin, C., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1619651 · Cited by 34
“TNF-α downregulation is likely to be responsible for such performance because the in fl ammatory cytokines TNF-α can increase matrix metallo-proteinase (MMP) secretion and collagen degradation and suppress collagen I/III synthesis [23].”
The use of wound healing assessment methods in psychological studies: A review and recommendations
Koschwanez, H. E., & Broadbent, E. (2010) · British Journal of Health Psychology · doi:10.1348/135910710x524633 · Cited by 35
Biofilm and Equine Limb Wounds
Jørgensen, E., Bjarnsholt, T., & Jacobsen, S. E. (2021) · Animals · doi:10.3390/ani11102825 · Cited by 34
Harnessing Multifaceted Next-Generation Technologies for Improved Skin Wound Healing
Bhar, B., Chouhan, D., Pai, N., & Mandal, B. B. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00880 · Cited by 32
Xanthine Oxidoreductase: A Novel Therapeutic Target for the Treatment of Chronic Wounds?
Fernandez, M. L., Stupar, D., Croll, T. I., Leavesley, D. I., & Upton, Z. (2017) · Advances in Wound Care · doi:10.1089/wound.2016.0724 · Cited by 32
“7,20,21 IL-1 b is a potent mediator of inflam-mation and is elevated in wound fluids and tissues from chronic venous leg ulcers.”
InfluentialBurian, E. A., Karlsmark, T., Nørregaard, S., Kirketerp‐Møller, K., Kirsner, R. S., Franks, P. J., Quéré, I., & Moffatt, C. J. (2021) · International Wound Journal · doi:10.1111/iwj.13642 · Cited by 29
Kroeze, K. L., Vink, L., Boer, E. M. D., Scheper, R. J., van Montfrans, C., & Gibbs, S. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00789.x · Cited by 28
Li, M., Li, F., Wang, T., Zhao, L., & Shi, Y. (2019) · Journal of Biomaterials Applications · doi:10.1177/0885328219873254 · Cited by 26
Evidenz der Kompressionstherapie
Konschake, W., Valesky, E. M., Stege, H., & Jünger, M. (2017) · Der Hautarzt · doi:10.1007/s00105-017-3999-z · Cited by 25
Latest Innovations in the Treatment of Venous Disease
Attaran, R. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7040077 · Cited by 24
“Venous ulcer levels of inflammatory cytokines IL-1 and interferon-γ fall with compression therapy [39].”
BackgroundProteomics and Metabolomics forIn SituMonitoring of Wound Healing
Kalkhof, S., Förster, Y., Schmidt, J. R., Schulz, M. C., Baumann, S., Weißflog, A., Gao, W., Hempel, U., Eckelt, U., Rammelt, S., et al. (2014) · BioMed Research International · doi:10.1155/2014/934848 · Cited by 25
“In the last years, several proteins, especially inflammatory mediators, growth factors and cytokines [3, 4], proteases [5, 6], and oxidative stress related proteins [7, 8], were identified in WF which can be used to characterize and classify the effect on different phases of the wound healing process and thereby can b…”
BackgroundThe application of L-PRP in AIDS patients with crural chronic ulcers: A pilot study
Cieslik-Bielecka, A., Skowroński, R., Jędrusik-Pawłowska, M., & Pierchała, M. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.10.002 · Cited by 23
The effect of Mindfulness-Based Stress Reduction on wound healing: a preliminary study
Meesters, A., Meevissen, Y. M. C., Weijzen, C. A. H., Buurman, W. A., Losen, M. H., Schepers, J., Thissen, M. R. T. M., Alberts, H. J. E. M., Schalkwijk, C. G., & Peters, M. L. (2017) · Journal of Behavioral Medicine · doi:10.1007/s10865-017-9901-8 · Cited by 24
“Excessive inflammation delays wound healing; indeed higher concentrations of pro-inflammatory cytokines have been found in chronic wounds (Beidler et al. 2009).”
BackgroundWhich dressings reduce inflammation and improve venous leg ulcer healing
Raffetto, J. D. (2014) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355514529225 · Cited by 21
“In addition, as the VLU healed the level of the anti-inflammatory cytokine IL-1 Ra increased at 4 weeks following compression.(9) The importance of this study was to demonstrate the inflammatory and anti-inflammatory cytokines present in VLU, and how compression therapy is able to modulate the expression and promote V…”
BackgroundInfluentialPertusi, G., Tiberio, R., Graziola, F., Boggio, P. S., Colombo, E., & Bozzo, C. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00762.x · Cited by 21
“Thus, inflammation, which is crucial in the early phase of wound healing, should resolve to accelerate recovery.(2,6,10,11) Venous insufficiency accounts for 75% of chronic leg ulcers.”
BackgroundCompression therapy in venous diseases: physical assumptions and clinical effects
Berszakiewicz, A., Sieroń, A., Krasiński, Z., Cholewka, A., & Stanek, A. (2019) · Advances in Dermatology and Allergology · doi:10.5114/ada.2019.86990 · Cited by 21
Chronic Venous Disease of the Lower Extremities: A State-of-the Art Review
Attaran, R., & Carr, J. G. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100538 · Cited by 23
Filkor, K., Németh, T., Nagy, I., Kondorosi, É., Urbán, E. Z., Kemény, L. V., & Szolnoky, G. (2015) · International Wound Journal · doi:10.1111/iwj.12473 · Cited by 20
“Clinical studies in wound healing mostly focus on local alterations of inflammatory cytokine expressions (9); however, a novel study found that infected wounds produced an upregulation of circulating inflammatory cytokine pattern compared with non-infected ones (8).”
BackgroundKrzystek‐Korpacka, M., Wiśniewski, J. Ł., Fleszar, M. G., Bednarz-Misa, I. S., Bronowicka-Szydełko, A., Gacka, M., Masłowski, L., Kędzior, K., Witkiewicz, W., & Gamian, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5965721 · Cited by 20
Myeloid Cells in Cutaneous Wound Repair
Cash, J. L., & Martin, P. B. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0017-2015 · Cited by 20
Compression Therapy Is Not Contraindicated in Diabetic Patients with Venous or Mixed Leg Ulcer
Mosti, G. B., Cavezzi, A., Bastiani, L., & Partsch, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113709 · Cited by 18
“In addition, a positive effect on inflammatory cytokines was demonstrated as compression is able to decrease the inflammatory mediators and increase their antagonists [9,10].”
BackgroundModalities to Treat Venous Ulcers: Compression, Surgery, and Bioengineered Tissue
Gould, L. J., Dosi, G., Couch, K. S., Gibbons, G. W., Howell, R. S., Brem, H., & Tomic‐Canic, M. (2016) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000002677 · Cited by 18
Nair, H. K. R., Mosti, G. B., Atkin, L., Aburn, R., Hussin, N. A., Naresh, G., Narayanan, S., Ritchie, G., Samuriwo, R., Sandy‐Hodgetts, K., et al. (2024) · Journal of Wound Care · doi:10.12968/jowc.2024.33.sup10b.s1 · Cited by 17
Diaz, J. A., Gianesini, S., & Khalil, R. A. (2025) · International Angiology · doi:10.23736/s0392-9590.24.05339-2 · Cited by 22
Qi, M., Zhu, X., Yu, X., Ai, M., Cai, W., Du, B., Hou, B., & Qiu, L. (2021) · Nanomaterials · doi:10.3390/nano11112830 · Cited by 16
What is the Medical Rationale for the Treatment of Varicose Veins?
Meissner, M. H. (2012) · Phlebology The Journal of Venous Disease · doi:10.1258/phleb.2012.012s17 · Cited by 15
A dual compression system: preliminary clinical insights from the US
Lantis, J. C., Barrett, C., Couch, K. S., Ehmann, S., Greenstein, E., Ostler, M., & Tickner, A. (2020) · Journal of Wound Care · doi:10.12968/jowc.2020.29.sup9.s29 · Cited by 14
Conde‐Montero, E., Bohbot, S., Sanz, R. G., Vázquez, A. P., Marín, L. R., Jerónimo, L. P., Sánchez, J. L. G., & de la Cueva, P. (2020) · JMV-Journal de Médecine Vasculaire · doi:10.1016/j.jdmv.2020.10.123 · Cited by 14
Theory and Practice of Compression Therapy for Treating and Preventing Venous Ulcers
Montero, E. C., Perrucho, N. S., & Dobao, P. D. L. C. (2020) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2020.10.022 · Cited by 14
Krzystek‐Korpacka, M., Kędzior, K., Masłowski, L., Mierzchała-Pasierb, M., Bednarz‐Misa, I., Bronowicka-Szydełko, A., Kubiak, J., Gacka, M., Płaczkowska, S., & Gamian, A. (2019) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/103845 · Cited by 14
Metadata
- Authors
- Beidler, S. K., Douillet, C. D., Berndt, D. F., Keagy, B. A., Rich, P. B., & Marston, W. A.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Marston, William A.
- Venue
- Journal of Vascular Surgery
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 49
- Issue
- 4
- Pages
- 1013-1020
- ISSN
- 0741-5214 (ISSN-L)
- PMC
- PMC4710545
- OpenAlex
- W2048226370
- Cited by
- 223
- References
- 46
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 17 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 16 · 2019: 11 · 2018: 14 · 2017: 16 · 2016: 13 · 2015: 9 · 2014: 11 · 2013: 7 · 2012: 11
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1568 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Journal of Vascular Surgery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (5 T32GM00845013)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Surgery › Diagnosis and Treatment of Venous Diseases
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- chronic venous insufficiency, leg ulcers, compression therapy, inflammatory cytokines, ulcer healing, TGF-β1, interleukin-1, interferon-gamma, interleukin-1 receptor antagonist, GM-CSF, IL-12
- MeSH terms
- Adult, Aged, Chronic Disease, Female, Humans, Male, Middle Aged, Time Factors, Varicose Ulcer, Venous Insufficiency, Wound Healing, Cytokines, Treatment Outcome, Inflammation Mediators, Stockings, Compression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review